SLRN
ACELYRIN
SLRN
SLRN
Delisted
SLRN was delisted on the 21st of May, 2025.
82 hedge funds and large institutions have $1.6B invested in ACELYRIN in 2023 Q2 according to their latest regulatory filings, with 82 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
82
Holders Change
+82
Holders Change %
–
% of All Funds
1.29%
Holding in Top 10
8
Holding in Top 10 Change
+8
Holding in Top 10 Change %
%
% of All Funds
0.13%
New
82
Increased
–
Reduced
–
Closed
–
Calls
$2.79M
Puts
$77K
Net Calls
+$2.72M
Net Calls Change
+$2.72M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$151M |
| 2 |
Citadel Advisors
Miami,
Florida
|
$121M |
| 3 |
O
OrbiMed
New York
|
$111M |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
$86.9M |
| 5 |
VP
venBio Partners
San Francisco,
California
|
$80.6M |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Bank of America
Charlotte,
North Carolina
| $38.5K | +$38.5K | +1,841 | New |
|
77
Osaic Holdings
Scottsdale,
Arizona
| $25K | +$25K | +1,194 | New |
|
78
Wells Fargo
San Francisco,
California
| $4.68K | +$4.68K | +224 | New |
|
79
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $4.49K | +$4.49K | +215 | New |
|
80
US Bancorp
Minneapolis,
Minnesota
| $3.89K | +$3.89K | +186 | New |
|
|
PTC
81
Private Trust Company
Cleveland,
Ohio
| $3.11K | +$3.11K | +149 | New |
|
|
FDCC
82
Foster Dykema Cabot & Co
Waltham,
Massachusetts
| $1K | +$1K | +51 | New |
|